Interim Condensed Consolidated Statements of Cash Flows (Current Period Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash Flows From Operating Activities:
Net income	$ 13,229	$ 13,805
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	7,900	6,956
Provision for doubtful accounts receivable	1,503	806
Equity in earnings of unconsolidated investments	(1,913)	(3,806)
Distributions from unconsolidated investments	5,317	2,022
Gains on sale of marketable securities	(136)	(230)
Deferred income taxes	(1,868)	(1,171)
Stock–based compensation	482	498
Changes in operating assets and liabilities, net of the effect of acquisitions:
Restricted cash and cash equivalents	1,285	(5,125)
Accounts receivable	(2,941)	(1,800)
Income tax receivable		5,933
Inventories	(114)	102
Prepaid expenses and other assets	(1,769)	(1,785)
Trade accounts payable	4,923	393
Accrued payroll	(22,783)	(1,858)
Amounts due to third party payors	889	(175)
Other current liabilities and accrued risk reserves	8,123	6,807
Other noncurrent liabilities	646	572
Deferred revenue	2,375	2,904
Net cash provided by operating activities	15,148	24,848
Cash Flows From Investing Activities:
Additions to property and equipment	(9,271)	(6,366)
Investments in unconsolidated limited liability companies	(706)
Investments in notes receivable	(767)
Collections of notes receivable	32	394
Change in restricted cash and cash equivalents	(4,519)	(688)
Purchase of marketable securities	(21,382)	(22,193)
Sale of marketable securities	24,453	22,055
Net cash used in investing activities	(12,160)	(6,798)
Cash Flows From Financing Activities:
Tax benefit from stock–based compensation	108
Principal payments under capital lease obligations	(238)
Dividends paid to preferred stockholders	(2,168)	(2,168)
Dividends paid to common stockholders	(4,496)	(4,236)
Issuance of common shares	6,476
Repurchase of common shares		(4,700)
Entrance fee deposits	467	157
Change in deposits	(705)	35
Net cash used in financing activities	(556)	(10,912)
Net Increase in Cash and Cash Equivalents	2,432	7,138
Cash and Cash Equivalents, Beginning of Period	81,705	66,701
Cash and Cash Equivalents, End of Period	84,137	73,839
Supplemental disclosure of non-cash investing and financing activities:
Buildings, personal property, and obligations recorded under capital lease agreements	$ 39,032